Leaders from Amgen and Celltheon Set to Keynote BPI West

Specialists from every discipline and stage of development aim to achieve the common goals of optimizing speed, reducing cost, and improving quality from basic research to commercialization. What helps the learning curve is to benchmark best practices from the exclusive experience of the top minds in the biopharmaceutical industry.

The leading experts from Amgen and CellTheon will get together at BPI West in Oakland, CA (March 14-17, 2016) to share their exclusive case studies and new data and evaluate the different approaches that are being utilized to streamline and accelerate development and production across:

- Basic Research & Discovery
- Early Stage Process Development & Pre-Clinical Manufacturing
- Late Stage Process Development & Clinical Manufacturing
- Commercial Manufacturing & Beyond

The following keynotes have been announced:

Amita Goel, MSc. Founder, and CEO, Celltheon will be presenting on Innovative Technologies for the Expression of Next Generation Bio Therapeutics;

Rohini Deshpande, Ph.D. Executive Director, Process and Product Development, Amgen will give a talk on End-to-End Integration;

Ran Zheng, Ph.D., Executive Director, Plant Manager, Amgen is joining BPI West with a presentation called “Unleashing the Power of Innovation to Tackle Biomanufacturing's Greatest Challenges, Fuel Growth and Drive Value Creation.”

To see more speakers and to get the most up-to-date brochure, click here. 

Don’t miss the chance to learn the innovative strategies and technologies and help move the pipeline of next generation drug candidates closer to approval!

Register before Friday, January 22nd and save $400 – Simply use the code BPIWEST16BL, to save. 

Follow @Futurebiopharma

Share this article with your social network, just click below to share now!

Share |

A look at Genentech’s strategy for Research and Development

Today, we feature a video from BIO-Europe Spring. Mike Crowley at Genentech who works in the Research and Early Development portfolio shares some insight on his group and how they work to develop drugs from discovery through clinical proof of concept. His company is unique as they also the company has two arms with the same function – Roche also has a research and development arm. Although the two have the same overarching company, it allows for a diverse work style within the parent company and allows each branch to reach their desired products and portfolios.

In this interview, Mike shares:

• - Michael’s background and how he came to start working with this Research and Early Development Group
• - How to get the attention of this group to schedule meetings with them while at partnering events.
• - Genentech’s focus on Oncology and Inflammatory diseases and how they will differentiate their products moving forward

During the interview, he makes the statement “the abundance of therapies on the market doesn’t equate to all the needs of the patients being met.” They take the effort to really understand the disease state of the patients who aren’t responding to existing therapies.

Watch the full interview here.

Are you intersted in finding out more about our BioEurope Event Series?  The next event will take place  is BIO-Europe which will take place November 3-5 in Frankfurt, Germany.  Visit the webpage to sign up for email updates and your opportunity to register at the lowest rate.

Share this article with your social network, just click below to share now!

Share |

Limited time offer to attend the 2nd Annual Business of Biosimilars

As a reader of Future of Biopharma, we'd like to extend to you a special offer. For five days only you will have the opportunity to save $700 off the standard registration rate at the 2nd Annual Business of Biosimilars Conference. This WEB ONLY offer is valid THROUGH MONDAY, JULY 26th. Please use code XP1586WEB to receive this discount. That's a Savings of $700 for a 3 day pass!

We know that this has been a tough year to get approval to attend events, but there's only ONE event your industry, key partners AND competitors will be at this year...Business of Biosimilars in September in Boston. In addition to saving $700 when you register through this offer, you will get access to a full day seminar on Strategies to Expedite Approval of Your Follow-On Biologic: From Drug Discovery to Post Approval, a dinner workshop on IP Protection and Patent Litigation, and over 30 expert faculty members including representatives from Sandoz, Biogen IDEC Inc., Hospira, Sanofi-Aventis, the FTC and much more.

Visit the webpage here to find out more information on the speakers and topics of this event:
http://bit.ly/cA9IaI

Share this article with your social network, just click below to share now!

Share |